BSL Q3 FY26: Revenue Rs167 Cr flat YoY, PAT drops 61% to Rs1.2 Cr

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

BSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹141.15

prior close

₹141.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+0.9% vs market

Other Textile Products peers, median of 178sector+0.2%+1.8% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.8 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.1

15m

-1.9

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9+1.0+0.9+0.2+1.8

Next day

+2.1+0.5+1.7-0.6+2.7

-2.2-0.0-2.2-0.5-1.7

-2.4-1.5-0.9-1.0-1.4

-7.2-2.2-5.0-1.8-5.4

-5.4-1.2-4.2-2.1-3.3

-6.5-2.4-4.1-3.3-3.2

15d

-10.2-8.8-1.3-9.1-1.1

-9.4-8.3-1.1-8.7-0.6

-17.1-3.5-13.6-5.8-11.3

-10.8+6.4-17.2-0.5-10.3

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 178Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSL Limited posted Q3 FY26 revenue of Rs167 Cr (down 1.7% YoY), EBITDA of Rs13 Cr at 7.9% margin (down 176 bps), and PAT of Rs1.2 Cr (down 61% YoY). For 9M FY26, revenue was Rs509 Cr (down 0.5%), EBITDA Rs39.5 Cr at 7.7% margin, PAT Rs3.4 Cr (down 57%). Management cited softer demand and pricing pressure but noted 42 bps QoQ margin improvement and early signs of demand stabilization.

Likely market impact

Sharp PAT decline and margin compression weigh on results, though modest sequential improvement and easing input costs offer some support.